Coronavirus
-
New year begins on a happy note as India’s expert panel clears Oxford vaccine, Covishield
Oxford vaccine: India has moved one step closer to getting its Covid-19 vaccine rollout approved as the expert panel has cleared use of Covishield, ... -
Following standard procedure can help tackle new virus strain, say Experts
The new virus strain: It has scared most people and now they fear that it might be an even bigger threat than the existing ... -
Covid-19: ‘Will prioritise 30 cr people, says Health Minister Harsh Vardhan
Health Minister Harsh Vardhan: The government has prioritised 30 crore people for the vaccine against the coronavirus, assures the Union Health Minister Harsh Vardhan ... -
Centre aims to vaccinate 30 crore against Covid-19 in early phase, Government releases some FAQs on vaccination drive
FAQs on vaccination drive: As India prepares for the one of the world’s largest vaccination drive against Coronavirus infection early next year, Union Health ... -
Covid-19 vaccine tracking: Covaxin phase 1 trials show promising results
Covaxin phase 1 trials: Results of phase 1 trials of Covaxin vaccine were released in a preprint paper “A Phase 1: Safety and Immunogenicity ... -
100-200 people will be vaccinated each says centre ahead of vaccination drive
Vaccination Drive: As India moves towards its aim of carrying a vaccination drive, the central government has announced a few guidelines ahead of the ... -
Uttar Pradesh government said of increasing vaccine storage capacity to 2.03L litres by 15 December
Uttar Pradesh government: UP’s chief minister Yogi Adityanath has set a deadline of December 15 to increase state’s vaccine storage capacity to 2.03 lakh ... -
Covid-19 vaccine: SII & Bharat Biotech emergency vaccine approval put on hold, DCGI cites lack of data
SII & Bharat Biotech: India’s hopes of getting Covid-19 vaccines in a matter of days flickered away – India might have to wait just ... -
First logistics blueprints released by expert committee regarding Covid-19 vaccination drive in India
First logistics blueprints: After Pfizer and Serum Institute of India approached India’s medical regulatory body DCGI seeking approval for their vaccine against Covid-19, Hyderabad-based ... -
Serum Institute of India applies for emergency use approval of Covishield, becomes first Indian firm to do so
Serum Institute of India: On Sunday, Serum Institute of India became the first indigenous pharma firm to apply for emergency use of Covishield, the ...
